Real-World Evidence for Label Expansion: Identifying Off-Label Use Trends in the Hospital Setting

Josine Kuiper

Nikita Jeswani

Jetty Overbeek

Real-World Evidence for Label Expansion: Identifying Off-Label Use Trends in the Hospital Setting

Presented during the ISPOR 2026 conference in Philadelphia, PA, our poster addresses the role that Real-World Evidence (RWE) plays in informing regulatory and clinical decisions on label expansion for approved medicines.

Access the poster

Contact us

For more information about how Lumanity can support you with your RWE needs and strategy, please contact us.

Resource

Real-World Evidence (RWE) in Phenylketonuria (PKU) and Other Hyperphenylalaninaemias (HPAs)

Take a look

Resource

How to: Test and Validate a Value Proposition

Take a look

Resource

Turning Raw Strategy into Irresistable Creative

Take a look

Resource

How to: Bridge Evidence Gaps and Address Uncertainty with Structured Expert Elicitation

Take a look

Woman presenting during a video conference call

Resource

Speakers Bureau Support, Executed with Precision

Take a look

Resource

Launch Excellence Health Check

Take a look

Resource

Master Rare Disease RWE with Lumanity: A Practical Playbook

Take a look

Resource

How to: Develop a Successful Health Technology Assessment Strategy

Take a look

Resource

GP Consultations for Herpes Zoster After COVID‑19 Vaccination: A Self‑Controlled Cohort Study Based on Electronic Health Record Data from the Netherlands

Take a look

Real-World Evidence for Label Expansion: Identifying Off-Label Use Trends in the Hospital Setting

Contact us

Related